Skip to Main Content

Paper Details

Attitudes of clinicians following large-scale pharmacogenomics implementation.
Pharmacogenomics J
61
2016
Participants, patient, patients, pharmacogenomics variants
Adult, Aged, Attitude of Health Personnel, Drug-Related Side Effects and Adverse Reactions, Female, Genotype, Health Knowledge, Attitudes, Practice, Humans, Male, Middle Aged, Perception, Pharmacogenetics, Pharmacogenomic Testing, Pharmacogenomic Variants, Phenotype, Physicians, Precision Medicine, Predictive Value of Tests, Risk Assessment, Risk Factors, Surveys and Questionnaires, Young Adult
Author NameAffiliation
Josh F PetersonVanderbilt University Medical Center
Josh F PetersonVanderbilt University Medical Center
Julie R FieldVanderbilt Institute for Clinical and Translational Research
Yaping ShiVanderbilt University Medical Center
Jonathan S SchildcroutVanderbilt University Medical Center
Jonathan S SchildcroutVanderbilt University Medical Center
Joshua C DennyVanderbilt University Medical Center
Joshua C DennyVanderbilt University Medical Center
Tracy L McGregorVanderbilt University Medical Center
Sara L Van DriestVanderbilt University Medical Center
Sara L Van DriestVanderbilt University Medical Center
Jill M PulleyVanderbilt Institute for Clinical and Translational Research
Ira M LubinCenters for Disease Control and Prevention
Michael LaposataUniversity of Texas Medical Branch
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
E ClaytonVanderbilt University Medical Center
E ClaytonCenter for Biomedical Ethics and Society, Vanderbilt University Medical Center
  • 1 - 18

Datasets

Release 1.2